Breast radiation microseed registry for certain early breast cancers
Part of Cancer, Skin clinical trials.
This registry study collects information about people with certain early breast cancer who receive a tiny radiation “microseed” placed in the breast after surgery. It may help doctors understand who benefits and how the treatment is done safely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have breast cancer of the duct type: invasive breast cancer or in-situ ductal cancer (DCIS)
- You had breast-conserving surgery and lymph node testing (sentinel lymph node biopsy or axillary node dissection with at least 6 nodes checked)
- Your surgical margins are clear (no tumor at the edge for invasive cancer, or at least 2 mm for DCIS)
- Your tumor is 3 cm or smaller, and you are age 50 or older
- You are able to sign consent and come for follow-up
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This registry study tracks people with early-stage, single-area breast cancer to understand outcomes when radiation is given during breast-conserving surgery. It may help doctors improve treatment planning for patients like you.
This trial tests a new, shorter radiation treatment given all at once after breast-conserving surgery for early-stage breast cancer. It is for people with small tumors that have not spread far, and aims to reduce side effects and visits to the clinic.
This trial tests whether radiation therapy alone is safe and effective for women 40 and older with early-stage breast cancer who have not had lymph node sampling. It aims to simplify treatment while maintaining good outcomes.
This trial is testing whether placing a tiny radioactive seed in your breast tumor before chemotherapy can help doctors see the best response and improve long-term outcomes. Participants get standard chemo plus the seed, and the study checks how often the tumor completely disappears.
This registry collects information from pre- or perimenopausal women with early breast cancer who are treated with standard care, plus tumor testing like MammaPrint®. It may help doctors better understand which treatments work best for different risk groups.
This study collects health information about people who have had a breast cancer recurrence after breast-conserving (breast-saving) surgery. It helps researchers understand what happens after initial treatment and how local recurrences are managed.
Hear when a new Breast Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.